Overview:

PKN1/PRK1 belongs to the protein kinase C superfamily which is activated by Rho family of small G proteins. PKN1/PRK1 is known to mediate the Rho-dependent signaling pathway and it can be activated by phospholipids and by limited proteolysis (1). PDPK1/PDK may also mediate insulin signals to the actin cytoskeleton and the proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggest its role in signal transduction related to apoptosis. PKN1/PRK signaling stimulates AR activity in the presence of adrenal androgens and in the presence of an AR antagonist (2).

Gene Aliases:

GPSN2; MRT14; SC2; TER; PRK1, DBK, PKN1, PKN, MGC46204, PAK1, PRKCL1, PKC-L1

Genbank Number:

NM_138501
NM_002741

References:

1. Amano, M.et.al: Identification of a putative target for rho as the serine-threonine kinase protein kinase N. Science 271: 648-651, 1996.

2. Metzger, E. et.al: A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J. 22: 270-280, 2003.